Saltar al contenido
Merck

681676

Wortmannin

≥95% (HPLC), PI3K inhibitor, liquid

Sinónimos:

InSolution Wortmannin, MLCK Inhibitor II

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Acerca de este artículo

Fórmula empírica (notación de Hill):
C23H24O8
Peso molecular:
428.43
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥95% (HPLC)
Form:
liquid
Storage condition:
OK to freeze, desiccated (hygroscopic), protect from light
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


Nombre del producto

Wortmannin, InSolution, ≥95%, fungal metabolite that acts as a selective, cell-permeable and irreversible inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase)

Quality Segment

description

Merck USA index - 14, 10053

assay

≥95% (HPLC)

form

liquid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, desiccated (hygroscopic), protect from light

shipped in

wet ice

storage temp.

−20°C

General description

Wortmannin is a fungal metabolite known for its potent and selective inhibitory effects onphosphatidylinositol 3-kinase (PI 3-kinase). It serves as a cell-permeable and irreversible inhibitor, demonstrating an IC50 of 5 nM in both purified preparations and cytosolic fractions. When fibroblasts are preincubated with wortmannin, it effectively abolishes the formation of Ins (3,4,5) P3 mediated byplatelet-derived growth factor (PDGF). Wortmannin blocks the catalytic activity of PI 3-kinase without interfering with upstream signaling events, making it a valuable tool for studying PI 3-kinase pathways. Additionally, it inhibits the metabolic effects of insulin in isolated rat adipocytes without affecting the insulin receptor′s tyrosinekinase activity. Wortmannin inhibits MAP kinase activation induced by platelet-activating factor in guinea pig neutrophils at concentrations ranging from 0.2 to 0.3 µM. It also demonstrates the ability to inhibit osteoclastic bone resorption. While it primarily targets PI 3-kinase, wortmannin can inhibit other kinases, such as myosin light chain kinase, with an IC50 of 200 nM, and PI 4-kinase at concentrations 100-fold higher than those required for PI3-kinase inhibition. Wortmannin also blocks phospholipase D activity. This steroid metabolite can inhibit human non-small cell lung cancer (NSCLC) both in vitro and in vivo. It acts as an effective radio sensitizer, increasing the sensitivity of NSCLC cells to ionizing radiation.

Application

Wortmannin has been used:
  • to treat the cells transfected withspecific vectors to investigate its role as an autophagy inhibitor
  • as a classical autophagy inhibitor to evaluate its effects on autophagic flux in non-small cell lung cancer (NSCLC) cells, specifically H460 cells
  • in inhibitor treatment experiments to inhibit autophagy and also used along with bafilomycin A1 to inhibit lysosomal degradation

Packaging

Packaged under inert gas

Physical form

A 10 mM (1 mg/233 µl) solution of Wortmannin (Cat. No. 681675) in DMSO.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Harmful (C)


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

Clase de almacenamiento

10 - Combustible liquids

wgk

WGK 2

flash_point_f

188.6 °F - closed cup - (Dimethylsulfoxide)

flash_point_c

87 °C - closed cup - (Dimethylsulfoxide)



Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos